Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imfinzi (durvalumab)
Pharma
FDA expands Padcev-Keytruda combo to more MIBC patients
Padcev and Keytruda have become the first muscle-invasive bladder cancer treatment that covers patients regardless of cisplatin eligibility.
Angus Liu
Jul 10, 2026 1:10pm
AZ's Imfinzi, Imjudo combo polishes case in early liver cancer
Jun 1, 2026 8:24am
AZ gains on Merck with 2nd bladder cancer nod for Imfinzi
May 28, 2026 4:39pm
AZ’s Imfinzi gains ground on Keytruda in bladder cancer race
May 14, 2026 11:52am
Another AstraZeneca Emerald glimmers in liver cancer
Apr 2, 2026 10:12am
China indicts AstraZeneca and former exec Leon Wang
Feb 11, 2026 11:13am
